{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:58:10Z","timestamp":1794373090642,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T00:00:00Z","timestamp":1331596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10620-012-2116-5","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T09:21:28Z","timestamp":1331544088000},"page":"1887-1898","source":"Crossref","is-referenced-by-count":88,"title":["Epstein-Barr Virus Infection Is Common in Inflamed Gastrointestinal Mucosa"],"prefix":"10.1007","volume":"57","author":[{"given":"Julie L.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh B.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon C.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo L.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Gulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"2116_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10120-003-0265-0","volume":"7","author":"P Correa","year":"2004","unstructured":"Correa P, Piazuelo MB, Camargo MC. The future of gastric cancer prevention. Gastric Cancer. 2004;7:9\u201316.","journal-title":"Gastric Cancer"},{"key":"2116_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2353\/jmoldx.2008.080023","volume":"10","author":"ML Gulley","year":"2008","unstructured":"Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn. 2008;10:279\u2013292.","journal-title":"J Mol Diagn"},{"key":"2116_CR3","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","volume":"91","author":"S Imai","year":"1994","unstructured":"Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA. 1994;91:9131\u20139135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2116_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0046-8177(96)90133-1","volume":"27","author":"ML Gulley","year":"1996","unstructured":"Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol. 1996;27:20\u201327.","journal-title":"Hum Pathol"},{"key":"2116_CR5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5858\/2003-127-0478-SGSTEV","volume":"127","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Molot R. Severe gastritis secondary to Epstein-Barr viral infection. Unusual presentation of infectious mononucleosis and associated diffuse lymphoid hyperplasia in gastric mucosa. Arch Pathol Lab Med. 2003;127:478\u2013480.","journal-title":"Arch Pathol Lab Med"},{"key":"2116_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1066896908316905","volume":"19","author":"SR Owens","year":"2011","unstructured":"Owens SR, Walls A, Krasinskas AM, Rund CR. Epstein-barr virus gastritis: rare or rarely sampled? A case report. Int J Surg Pathol. 2011;19:196\u2013198.","journal-title":"Int J Surg Pathol"},{"key":"2116_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10620-009-0710-y","volume":"55","author":"AD Toll","year":"2010","unstructured":"Toll AD, Malik S, Tuluc M. Ulcerative gastritis secondary to Epstein-Barr viral infection. Dig Dis Sci. 2010;55:218\u2013219.","journal-title":"Dig Dis Sci"},{"key":"2116_CR8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mge.2000.107715","volume":"52","author":"Y Kitayama","year":"2000","unstructured":"Kitayama Y, Honda S, Sugimura H. Epstein-Barr virus-related gastric pseudolymphoma in infectious mononucleosis. Gastrointest Endosc. 2000;52:290\u2013291.","journal-title":"Gastrointest Endosc"},{"key":"2116_CR9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.190.4.567","volume":"190","author":"GJ Babcock","year":"1999","unstructured":"Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med. 1999;190:567\u2013576.","journal-title":"J Exp Med"},{"key":"2116_CR10","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","volume":"117","author":"SD Dojcinov","year":"2011","unstructured":"Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726\u20134735.","journal-title":"Blood"},{"key":"2116_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","volume":"34","author":"SD Dojcinov","year":"2010","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer\u2014a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405\u2013417.","journal-title":"Am J Surg Pathol"},{"key":"2116_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0046-8177(00)80197-5","volume":"31","author":"BG Schneider","year":"2000","unstructured":"Schneider BG, Gulley ML, Eagan P, Bravo JC, Mera R, Geradts J. Loss of p16\/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Hum Pathol. 2000;31:45\u201350.","journal-title":"Hum Pathol"},{"key":"2116_CR13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1440-1827.1997.tb04450.x","volume":"47","author":"J Arikawa","year":"1997","unstructured":"Arikawa J, Tokunaga M, Tashiro Y, et al. Epstein-Barr virus-positive multiple early gastric cancers and dysplastic lesions: a case report. Pathol Int. 1997;47:730\u2013734.","journal-title":"Pathol Int"},{"key":"2116_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<293::AID-PATH937>3.0.CO;2-C","volume":"183","author":"H Yanai","year":"1997","unstructured":"Yanai H, Takada K, Shimizu N, Mizugaki Y, Tada M, Okita K. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol. 1997;183:293\u2013298.","journal-title":"J Pathol"},{"key":"2116_CR15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1440-1827.1997.tb04509.x","volume":"47","author":"J Arikawa","year":"1997","unstructured":"Arikawa J, Tokunaga M, Satoh E, Tanaka S, Land CE. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol Int. 1997;47:360\u2013367.","journal-title":"Pathol Int"},{"key":"2116_CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jemt.1109","volume":"53","author":"D Hungermann","year":"2001","unstructured":"Hungermann D, Muller S, Spieker T, Lisner R, Niedobitek G, Herbst H. Low prevalence of latently Epstein-Barr virus-infected cells in chronic gastritis. Microsc Res Tech. 2001;53:409\u2013413.","journal-title":"Microsc Res Tech"},{"key":"2116_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/IJGC:34:2-3:087","volume":"34","author":"A Hirano","year":"2003","unstructured":"Hirano A, Yanai H, Shimizu N, et al. Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer. 2003;34:87\u201394.","journal-title":"Int J Gastrointest Cancer"},{"key":"2116_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-642-56515-1_6","volume":"258","author":"M Fukayama","year":"2001","unstructured":"Fukayama M, Chong JM, Uozaki H. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. Curr Top Microbiol Immunol. 2001;258:91\u2013102.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2116_CR19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/vim.1997.10.49","volume":"10","author":"X Jing","year":"1997","unstructured":"Jing X, Nakamura Y, Nakamura M, et al. Detection of Epstein-Barr virus DNA in gastric carcinoma with lymphoid stroma. Viral Immunol. 1997;10:49\u201358.","journal-title":"Viral Immunol"},{"key":"2116_CR20","doi-asserted-by":"crossref","unstructured":"Zur Hausen A, van Rees BP, van Beek J et al. Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J Clin Pathol. 2004;57:487\u2013491.","DOI":"10.1136\/jcp.2003.014068"},{"key":"2116_CR21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S1413-86702011000600014","volume":"15","author":"SK Shukla","year":"2011","unstructured":"Shukla SK, Prasad KN, Tripathi A, et al. Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases. Braz J Infect Dis. 2011;15:583\u2013590.","journal-title":"Braz J Infect Dis"},{"key":"2116_CR22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1099\/jmm.0.46580-0","volume":"55","author":"J Minoura-Etoh","year":"2006","unstructured":"Minoura-Etoh J, Gotoh K, Sato R, et al. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol. 2006;55:905\u2013911.","journal-title":"J Med Microbiol"},{"key":"2116_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00535-006-1981-0","volume":"42","author":"Y Kojima","year":"2007","unstructured":"Kojima Y, Mogaki M, Takagawa R, et al. A case of lymphoepithelioma-like carcinoma of the colon with ulcerative colitis. J Gastroenterol. 2007;42:181\u2013185.","journal-title":"J Gastroenterol"},{"key":"2116_CR24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","volume":"24","author":"MP Pender","year":"2003","unstructured":"Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol. 2003;24:584\u2013588.","journal-title":"Trends Immunol"},{"key":"2116_CR25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI117782","volume":"95","author":"JH Vaughan","year":"1995","unstructured":"Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest. 1995;95:1316\u20131327.","journal-title":"J Clin Invest"},{"key":"2116_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0961203306070009","volume":"15","author":"JB Harley","year":"2006","unstructured":"Harley JB, Harley IT, Guthridge JM, James JA. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus. 2006;15:768\u2013777.","journal-title":"Lupus"},{"key":"2116_CR27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11910-007-0038-y","volume":"7","author":"JD Lunemann","year":"2007","unstructured":"Lunemann JD, Munz C. Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep. 2007;7:253\u2013258.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2116_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.it.2007.03.002","volume":"28","author":"M Swanson-Mungerson","year":"2007","unstructured":"Swanson-Mungerson M, Longnecker R. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol. 2007;28:213\u2013218.","journal-title":"Trends Immunol"},{"key":"2116_CR29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1525-1578(10)60535-1","volume":"6","author":"JL Ryan","year":"2004","unstructured":"Ryan JL, Fan H, Glaser SL, Schichman SA, Raab-Traub N, Gulley ML. Epstein-Barr virus quantization by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004;6:378\u2013385.","journal-title":"J Mol Diagn"},{"key":"2116_CR30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/378808","volume":"37","author":"PD Ling","year":"2003","unstructured":"Ling PD, Vilchez RA, Keitel WA, et al. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003;37:1244\u20131249.","journal-title":"Clin Infect Dis"},{"key":"2116_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/1042819032000141310","volume":"45","author":"SL Glaser","year":"2004","unstructured":"Glaser SL, Gulley ML, Borowitz MJ, et al. Inter- and intra-observer reliability of Epstein-Barr virus detection in Hodgkin lymphoma using histochemical procedures. Leuk Lymphoma. 2004;45:489\u2013497.","journal-title":"Leuk Lymphoma"},{"key":"2116_CR32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.2910600513","volume":"60","author":"PH Levine","year":"1995","unstructured":"Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer.1995;60:642\u2013644.","journal-title":"Int J Cancer"},{"key":"2116_CR33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1200\/JCO.2004.08.061","volume":"22","author":"J Beek van","year":"2004","unstructured":"van Beek J, van Zur Hausen A, Klein Kranenbarg E, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664\u2013670.","journal-title":"J Clin Oncol"},{"key":"2116_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10120-003-0247-2","volume":"6","author":"K Oda","year":"2003","unstructured":"Oda K, Koda K, Takiguchi N, Nunomura M, Seike K, Miyazaki M. Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes. Gastric Cancer. 2003;6:173\u2013178.","journal-title":"Gastric Cancer"},{"key":"2116_CR35","first-page":"995","volume":"8","author":"YA Luqmani","year":"2001","unstructured":"Luqmani YA, Linjawi SO, Shousha S. Detection of Epstein-Barr virus in gastrectomy specimens. Oncol Rep. 2001;8:995\u2013999.","journal-title":"Oncol Rep"},{"key":"2116_CR36","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/1097-0142(19940501)73:9<2239::AID-CNCR2820730902>3.0.CO;2-#","volume":"73","author":"S Nakamura","year":"1994","unstructured":"Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer. 1994;73:2239\u20132249.","journal-title":"Cancer"},{"key":"2116_CR37","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199411000-00010","volume":"18","author":"ST Yuen","year":"1994","unstructured":"Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Pathol. 1994;18:1158\u20131163.","journal-title":"Am J Surg Pathol"},{"key":"2116_CR38","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.cgh.2006.05.025","volume":"4","author":"DR Morgan","year":"2006","unstructured":"Morgan DR, Dominguez RL, Keku TO, et al. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol. 2006;4:1103\u20131111.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2116_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","volume":"378","author":"ER Greenberg","year":"2011","unstructured":"Greenberg ER, Anderson GL, Morgan DR, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011;378:507\u2013514.","journal-title":"Lancet"},{"key":"2116_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00129039-200306000-00010","volume":"11","author":"HJ Cho","year":"2003","unstructured":"Cho HJ, Kim JY, Yoo J, Lee SS. Gastric carcinoma with lymphoid stroma: incidence of EBV and Helicobacter pylori infection. Appl Immunohistochem Mol Morphol. 2003;11:149\u2013152.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2116_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-230X(03)90002-9","volume":"90","author":"S Normark","year":"2003","unstructured":"Normark S, Nilsson C, Normark BH, Hornef MW. Persistent infection with Helicobacter pylori and the development of gastric cancer. Adv Cancer Res. 2003;90:63\u201389.","journal-title":"Adv Cancer Res"},{"key":"2116_CR42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.1442","volume":"201","author":"NA Wong","year":"2003","unstructured":"Wong NA, Herbst H, Herrmann K, et al. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. J Pathol. 2003;201:312\u2013318.","journal-title":"J Pathol"},{"key":"2116_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64516-6","volume":"157","author":"T Spieker","year":"2000","unstructured":"Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol. 2000;157:51\u201357.","journal-title":"Am J Pathol"},{"key":"2116_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jmv.1890380306","volume":"38","author":"AJ Wakefield","year":"1992","unstructured":"Wakefield AJ, Fox JD, Sawyerr AM, et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn\u2019s disease using the nested polymerase chain reaction. J Med Virol. 1992;38:183\u2013190.","journal-title":"J Med Virol"},{"key":"2116_CR45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jmv.20109","volume":"73","author":"T Gehlert","year":"2004","unstructured":"Gehlert T, Devergne O, Niedobitek G. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. J Med Virol. 2004;73:432\u2013438.","journal-title":"J Med Virol"},{"key":"2116_CR46","first-page":"691","volume":"45","author":"U Ruther","year":"1998","unstructured":"Ruther U, Nunnensiek C, Muller HA, Bader H, May U, Jipp P. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn\u2019s disease). Hepatogastroenterology. 1998;45:691\u2013699.","journal-title":"Hepatogastroenterology"},{"key":"2116_CR47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1572-0241.1999.01148.x","volume":"94","author":"H Yanai","year":"1999","unstructured":"Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K. Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterol. 1999;94:1582\u20131586.","journal-title":"Am J Gastroenterol"},{"key":"2116_CR48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5603\/FHC.2011.0049","volume":"49","author":"A Marszalek","year":"2011","unstructured":"Marszalek A, Marciniak R, Szkaradkiewicz A, et al. Inflammatory bowel disease\u2014is there something new in the immunological background? Folia Histochem Cytobiol. 2011;49:357\u2013362.","journal-title":"Folia Histochem Cytobiol"},{"key":"2116_CR49","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s10620-008-0639-6","volume":"54","author":"MM Maher","year":"2009","unstructured":"Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009;54:2456\u20132462.","journal-title":"Dig Dis Sci"},{"key":"2116_CR50","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3109\/00365521.2011.605466","volume":"46","author":"T Sipponen","year":"2011","unstructured":"Sipponen T, Turunen U, Lautenschlager I, Nieminen U, Arola J, Halme L. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease. Scand J Gastroenterol. 2011;46:1324\u20131333.","journal-title":"Scand J Gastroenterol"},{"key":"2116_CR51","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood.V79.7.1763.1763","volume":"79","author":"MA Baumann","year":"1992","unstructured":"Baumann MA, Paul CC. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. Blood. 1992;79:1763\u20131767.","journal-title":"Blood"},{"key":"2116_CR52","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/JVI.64.6.3033-3041.1990","volume":"64","author":"G Tosato","year":"1990","unstructured":"Tosato G, Tanner J, Jones KD, Revel M, Pike SE. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol. 1990;64:3033\u20133041.","journal-title":"J Virol"},{"key":"2116_CR53","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1128\/JVI.76.24.12543-12552.2002","volume":"76","author":"A Mauser","year":"2002","unstructured":"Mauser A, Holley-Guthrie E, Zanation A, et al. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F\u20131 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol. 2002;76:12543\u201312552.","journal-title":"J Virol"},{"key":"2116_CR54","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","volume":"22","author":"BF Israel","year":"2003","unstructured":"Israel BF, Kenney SC. Virally targeted therapies for EBV-associated malignancies. Oncogene. 2003;22:5122\u20135130.","journal-title":"Oncogene"},{"key":"2116_CR55","first-page":"55","volume":"117","author":"S Kenney","year":"2006","unstructured":"Kenney S, Theodore E. Woodward award: development of novel, EBV-targeted therapies for EBV-positive tumors. Trans Am Clin Climatol Assoc. 2006;117:55\u201374.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2116_CR56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrmicro2541","volume":"9","author":"EF Foxman","year":"2011","unstructured":"Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol. 2011;9:254\u2013264.","journal-title":"Nat Rev Microbiol"},{"key":"2116_CR57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MOG.0b013e32834d61e9","volume":"28","author":"VB Young","year":"2012","unstructured":"Young VB. The intestinal microbiota in health and disease. Curr Opin Gastroenterol. 2012;28:63\u201369.","journal-title":"Curr Opin Gastroenterol"},{"key":"2116_CR58","first-page":"331","volume":"39","author":"H Chai","year":"2009","unstructured":"Chai H, Brown RE. Field effect in cancer-an update. Ann Clin Lab Sci. 2009;39:331\u2013337.","journal-title":"Ann Clin Lab Sci"},{"key":"2116_CR59","doi-asserted-by":"crossref","first-page":"12844","DOI":"10.1128\/JVI.05853-11","volume":"85","author":"DG Meckes Jr","year":"2011","unstructured":"Meckes DG Jr, Raab-Traub N. Microvesicles and viral infection. J Virol. 2011;85:12844\u201312854.","journal-title":"J Virol"},{"key":"2116_CR60","first-page":"715","volume":"2011","author":"DM Pegtel","year":"1809","unstructured":"Pegtel DM, van de Garde MD, Middeldorp JM. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta. 1809;2011:715\u2013721.","journal-title":"Biochim Biophys Acta."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-012-2116-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2116-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T16:15:21Z","timestamp":1641140121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-012-2116-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,13]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["2116"],"URL":"https:\/\/doi.org\/10.1007\/s10620-012-2116-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,13]]}}}